Navigation Links
Use of Clinical Endpoint Adjudication Committees Finding Increasing Favor with Regulators
Date:3/28/2011

BALA CYNWYD, Pa., March 28, 2011 /PRNewswire/ -- Applied Clinical Intelligence, LLC (ACI), an industry leader in clinical endpoint adjudication committees and independent data monitoring committees (www.icommittees.com), announces the opening of registration for a complimentary breakfast seminar in Cambridge, MA. The 90-minute seminar will focus on aligning independent expert committees with development goals.  This is a unique opportunity to learn practical advice about effective design and management of Clinical Endpoint Committees (CECs) and Endpoint Adjudication Committees (EACs).

"The regulatory pressure for independent adjudication of composite endpoints is escalating, and we want to make sure that those involved in drug, biotech, and device development understand the potential regulatory issues," said Dr. Jonathan Seltzer, MD, MBA, FACC, President and CEO of ACI.  Please join us for this unique learning opportunity.  For your convenience, the seminar is being offered on both April 5th and April 6th in Cambridge, MA from 8:30 a.m. to 10 a.m. ACI will also host seminars in different regions over the next few months.  Registration details for this complimentary seminar are available at http://www.a-ci.com/index.php?id=62.

Topics will include:

  • Practical issues with adjudication of Composite Endpoints and MACE
  • Regulatory strategy for Clinical Endpoint Adjudication
  • Independent Expert Compensation and Sunshine Laws
  • Issues with Image Adjudication presented by Intrinsic Imaging (www.intrinsiccro.com)

Please also visit our iCommittees™ website for more information: www.icommittees.com.

About Applied Clinical Intelligence

ACI provides integrated and highly efficient risk reduction solutions for clinical research.  iCommittees™ is a comprehensive, independent expert committee solution offering management, regulatory-grade biostatistical support, automated processes and documentation expertise for Data Monitoring Committees (DSMBs) and EACs.  Founded in 2001, ACI is headquartered in the Philadelphia area and has deployed its automated solutions to hundreds of trials in over 50 countries.  For more information, please visit www.a-ci.com.

Contact:
Kelly Ryan
484-429-7200


'/>"/>
SOURCE Applied Clinical Intelligence, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global artificial pancreas devices system market to grow at ... Artificial Pancreas Devices System Market 2016-2020, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:1/17/2017)... 2017 The interventional radiology products market is ... USD 6.35 billion in 2016, at a CAGR of ... this market are rising incidence of chronic diseases, rising ... The global interventional radiology products market is ... the basis of type, the stents segment is expected ...
(Date:1/17/2017)... , January 17, 2017 Management to ... TyrNovo, Ltd.   KIT-302 Development On Track For An ... FDA in Q1 2017   ... Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), ... on Monday, January 23 rd at 8:30am Eastern Time to discuss the ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... ... Dr. Farhan Qureshi is an esteemed dentist who offers a full range of ... convenient office locations in Alexandria and Arlington, Virginia. Recently, Find Local Dentists has recognized ... This award confirms the fact that Dr. Qureshi’s patients have left highly favorable reviews ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the World ... with the donation of cochlear implants. In February 2017, the first three children ... fair chance of leading an independent life. This engagement builds on the support ...
(Date:1/18/2017)... ... , ... Floundering on New Year’s resolutions? Need an excuse to get back ... The U.S. Apple Association agrees and recommends starting each day with apples, a ... heart disease. , The U.S. Apple Association – which represents apple growers and producers ...
(Date:1/17/2017)... ... 2017 , ... Gym Source, America’s leading retailer of premium residential and commercial ... in Miami, FL. , “We are elated to be opening this new showroom,” explains ... designed to give clients a seamless and motivating shopping experience.” , Every fitness journey ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... ... concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting interview with ... magical moments that help everyone endure and pass through tough times, Dr. Bernie ...
Breaking Medicine News(10 mins):